A trial looking at rilvegostomig and datopotamab deruxtecan for non small cell lung cancer that has spread (TROPION-Lung10)

This trial is looking at rilvegostomig on its own or with datopotamab deruxtecan for non small cell lung cancer. It is comparing this to standard treatment.

The trial is for people whose cancer has spread into surrounding tissues or to distant parts of the body. This is locally advanced or metastatic cancer.

You pronounce rilvegostomig as ril–veh–gost-oh-mig.

You pronounce datopotamab deruxtecan as day-toe-pot-oh-mab deh-rux-tee-can. It is also called Dato-DXd for short.